Loading...
Header Logo
Keywords
Last Name
Institution

Professor Christian Burri

TitleHead of Department
InstitutionSwiss Tropical and Public Health Institute
DepartmentMedicines Research
AddressBasel
Switzerland
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Nzolo D, Kuemmerle A, Lula Y, Ntamabyaliro N, Engo A, Mvete B, Liwono J, Lusakibanza M, Mesia G, Burri C, Mampunza S, Tona G. Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo. Ther Adv Drug Saf. 2019; 10:2042098619864853. PMID: 31360433.
      View in: PubMed
    2. Ntamabyaliro NY, Burri C, Nzolo DB, Engo AB, Lula YN, Mampunza SM, Nsibu CN, Mesia GK, Kayembe JN, Likwela JL, Kintaudi LM, Tona GL. Drug use in the management of uncomplicated malaria in public health facilities in the Democratic Republic of the Congo. Malar J. 2018 May 03; 17(1):189. PMID: 29724210.
      View in: PubMed
    3. Vischer N, Pfeiffer C, Kealy J, Burri C. Increasing protocol suitability for clinical trials in sub-Saharan Africa: a mixed methods study. Glob Health Res Policy. 2017; 2:11. PMID: 29202079.
      View in: PubMed
    4. Vischer N, Pfeiffer C, Limacher M, Burri C. "You can save time if…"-A qualitative study on internal factors slowing down clinical trials in Sub-Saharan Africa. PLoS One. 2017; 12(3):e0173796. PMID: 28301530.
      View in: PubMed
    5. Vischer N, Pfeiffer C, Joller A, Klingmann I, Ka A, Kpormegbe SK, Burri C. The Good Clinical Practice guideline and its interpretation - perceptions of clinical trial teams in sub-Saharan Africa. Trop Med Int Health. 2016 Aug; 21(8):1040-1048. PMID: 27260671.
      View in: PubMed
    6. Pohlig G, Bernhard SC, Blum J, Burri C, Mpanya A, Lubaki JP, Mpoto AM, Munungu BF, N'tombe PM, Deo GK, Mutantu PN, Kuikumbi FM, Mintwo AF, Munungi AK, Dala A, Macharia S, Bilenge CM, Mesu VK, Franco JR, Dituvanga ND, Tidwell RR, Olson CA. Efficacy and Safety of Pafuramidine versus Pentamidine Maleate for Treatment of First Stage Sleeping Sickness in a Randomized, Comparator-Controlled, International Phase 3 Clinical Trial. PLoS Negl Trop Dis. 2016 Feb; 10(2):e0004363. PMID: 26882015.
      View in: PubMed
    7. Burri C, Yeramian PD, Allen JL, Merolle A, Serge KK, Mpanya A, Lutumba P, Mesu VK, Bilenge CM, Lubaki JP, Mpoto AM, Thompson M, Munungu BF, Manuel F, Josenando T, Bernhard SC, Olson CA, Blum J, Tidwell RR, Pohlig G. Efficacy, Safety, and Dose of Pafuramidine, a New Oral Drug for Treatment of First Stage Sleeping Sickness, in a Phase 2a Clinical Study and Phase 2b Randomized Clinical Studies. PLoS Negl Trop Dis. 2016 Feb; 10(2):e0004362. PMID: 26881924.
      View in: PubMed
    8. Ntuku HM, Ferrari G, Burri C, Tshefu AK, Kalemwa DM, Lengeler C. Feasibility and acceptability of injectable artesunate for the treatment of severe malaria in the Democratic Republic of Congo. Malar J. 2016 Jan 08; 15:18. PMID: 26747281.
      View in: PubMed
    9. Ferrari G, Ntuku HM, Burri C, Tshefu AK, Duparc S, Hugo P, Mitembo DK, Ross A, Ngwala PL, Luwawu JN, Musafiri PN, Ngoie SE, Lengeler C. An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study. Malar J. 2015 May 30; 14:226. PMID: 26024661.
      View in: PubMed
    10. Burri C, Ferrari G, Ntuku HM, Kitoto AT, Duparc S, Hugo P, Mitembo DK, Lengeler C. Delayed anemia after treatment with injectable artesunate in the Democratic Republic of the Congo: a manageable issue. Am J Trop Med Hyg. 2014 Oct; 91(4):821-823. PMID: 25071004.
      View in: PubMed
    11. Williams JR, Sprumont D, Hirtle M, Adebamowo C, Braunschweiger P, Bull S, Burri C, Czarkowski M, Fan CT, Franck C, Gefenas E, Geissbuhler A, Klingmann I, Kouyaté B, Kraehenbhul JP, Kruger M, Moodley K, Ntoumi F, Nyirenda T, Pym A, Silverman H, Tenorio S. Consensus standards for introductory e-learning courses in human participants research ethics. J Med Ethics. 2014 Jun; 40(6):426-8. PMID: 23959838.
      View in: PubMed
    12. Kuepfer I, Schmid C, Allan M, Edielu A, Haary EP, Kakembo A, Kibona S, Blum J, Burri C. Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness. PLoS Negl Trop Dis. 2012 Aug; 6(8):e1695. PMID: 22970329.
      View in: PubMed
    13. Burri C. An alternative form of melarsoprol in sleeping sickness: is an old drug always the best basis for a new one? Trends Parasitol. 2012 Sep; 28(9):354-5. PMID: 22867944.
      View in: PubMed
    14. Probst-Hensch N, Tanner M, Kessler C, Burri C, Künzli N. Prevention--a cost-effective way to fight the non-communicable disease epidemic: an academic perspective of the United Nations High-level NCD Meeting. Swiss Med Wkly. 2011; 141:w13266. PMID: 21901650.
      View in: PubMed
    15. Kuemmerle A, Dodoo AN, Olsson S, Van Erps J, Burri C, Lalvani PS. Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring. Malar J. 2011 Mar 09; 10:57. PMID: 21388536.
      View in: PubMed
    16. Kuepfer I, Hhary EP, Allan M, Edielu A, Burri C, Blum JA. Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda. PLoS Negl Trop Dis. 2011 Mar 01; 5(3):e968. PMID: 21407802.
      View in: PubMed
    17. Burri C. Chemotherapy against human African trypanosomiasis: is there a road to success? Parasitology. 2010 Dec; 137(14):1987-94. PMID: 20961469.
      View in: PubMed
    18. Paine MF, Wang MZ, Generaux CN, Boykin DW, Wilson WD, De Koning HP, Olson CA, Pohlig G, Burri C, Brun R, Murilla GA, Thuita JK, Barrett MP, Tidwell RR. Diamidines for human African trypanosomiasis. Curr Opin Investig Drugs. 2010 Aug; 11(8):876-83. PMID: 20721830.
      View in: PubMed
    19. Matovu E, Kuepfer I, Boobo A, Kibona S, Burri C. Comparative detection of trypanosomal DNA by loop-mediated isothermal amplification and PCR from flinders technology associates cards spotted with patient blood. J Clin Microbiol. 2010 Jun; 48(6):2087-90. PMID: 20410347.
      View in: PubMed
    20. Brun R, Blum J, Chappuis F, Burri C. Human African trypanosomiasis. Lancet. 2010 Jan 09; 375(9709):148-59. PMID: 19833383.
      View in: PubMed
    21. Kuepfer I, Burri C. Reflections on clinical research in sub-Saharan Africa. Int J Parasitol. 2009 Jul 15; 39(9):947-54. PMID: 19324048.
      View in: PubMed
    22. Blum JA, Schmid C, Burri C, Hatz C, Olson C, Fungula B, Kazumba L, Mangoni P, Mbo F, Deo K, Mpanya A, Dala A, Franco JR, Pohlig G, Zellweger MJ. Cardiac alterations in human African trypanosomiasis (T.b. gambiense) with respect to the disease stage and antiparasitic treatment. PLoS Negl Trop Dis. 2009; 3(2):e383. PMID: 19221604.
      View in: PubMed
    23. Blum JA, Zellweger MJ, Burri C, Hatz C. Cardiac involvement in African and American trypanosomiasis. Lancet Infect Dis. 2008 Oct; 8(10):631-41. PMID: 18922485.
      View in: PubMed
    24. Blum JA, Burri C, Hatz C, Kazumba L, Mangoni P, Zellweger MJ. Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis). Trop Med Int Health. 2007 Dec; 12(12):1422-32. PMID: 18076548.
      View in: PubMed
    25. Blum JA, Schmid C, Hatz C, Kazumba L, Mangoni P, Rutishauser J, la Torre A, Burri C. Sleeping glands? - The role of endocrine disorders in sleeping sickness (T.b. gambiense Human African Trypanosomiasis). Acta Trop. 2007 Oct; 104(1):16-24. PMID: 17767911.
      View in: PubMed
    26. Blum J, Schmid C, Burri C. Clinical aspects of 2541 patients with second stage human African trypanosomiasis. Acta Trop. 2006 Jan; 97(1):55-64. PMID: 16157286.
      View in: PubMed
    27. Schmid C, Richer M, Bilenge CM, Josenando T, Chappuis F, Manthelot CR, Nangouma A, Doua F, Asumu PN, Simarro PP, Burri C. Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II). J Infect Dis. 2005 Jun 01; 191(11):1922-31. PMID: 15871127.
      View in: PubMed
    28. Schmid C, Nkunku S, Merolle A, Vounatsou P, Burri C. Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness. Lancet. 2004 Aug 28-Sep 3; 364(9436):789-90. PMID: 15337407.
      View in: PubMed
    29. Nenortas E, Kulikowicz T, Burri C, Shapiro TA. Antitrypanosomal activities of fluoroquinolones with pyrrolidinyl substitutions. Antimicrob Agents Chemother. 2003 Sep; 47(9):3015-7. PMID: 12937017.
      View in: PubMed
    30. Bodley AL, Chakraborty AK, Xie S, Burri C, Shapiro TA. An unusual type IB topoisomerase from African trypanosomes. Proc Natl Acad Sci U S A. 2003 Jun 24; 100(13):7539-44. PMID: 12810956.
      View in: PubMed
    31. Burri C, Brun R. Eflornithine for the treatment of human African trypanosomiasis. Parasitol Res. 2003 Jun; 90 Supp 1:S49-52. PMID: 12811548.
      View in: PubMed
    32. Legros D, Ollivier G, Gastellu-Etchegorry M, Paquet C, Burri C, Jannin J, Büscher P. Treatment of human African trypanosomiasis--present situation and needs for research and development. Lancet Infect Dis. 2002 Jul; 2(7):437-40. PMID: 12127356.
      View in: PubMed
    33. Blum J, Burri C. Treatment of late stage sleeping sickness caused by T.b. gambiense: a new approach to the use of an old drug. Swiss Med Wkly. 2002 Feb 09; 132(5-6):51-6. PMID: 11971197.
      View in: PubMed
    34. Brun R, Schumacher R, Schmid C, Kunz C, Burri C. The phenomenon of treatment failures in Human African Trypanosomiasis. Trop Med Int Health. 2001 Nov; 6(11):906-14. PMID: 11703845.
      View in: PubMed
    35. Burri C, Keiser J. Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment. Trop Med Int Health. 2001 May; 6(5):412-20. PMID: 11348536.
      View in: PubMed
    36. Brun R, Burri C, Gichuki CW. The story of CGP 40 215: studies on its efficacy and pharmacokinetics in African green monkey infected with Trypanosoma brucei rhodesiense. Trop Med Int Health. 2001 May; 6(5):362-8. PMID: 11348531.
      View in: PubMed
    37. Burri C. Are there new approaches to roll back trypanosomiasis? Trop Med Int Health. 2001 May; 6(5):327-9. PMID: 11348526.
      View in: PubMed
    38. Blum J, Nkunku S, Burri C. Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis. Trop Med Int Health. 2001 May; 6(5):390-400. PMID: 11348533.
      View in: PubMed
    39. Keiser J, Burri C. Evaluation of quinolone derivatives for antitrypanosomal activity. Trop Med Int Health. 2001 May; 6(5):369-89. PMID: 11348532.
      View in: PubMed
    40. Keiser J, Stich A, Burri C. New drugs for the treatment of human African trypanosomiasis: research and development. Trends Parasitol. 2001 Jan; 17(1):42-9. PMID: 11137740.
      View in: PubMed
    41. Keiser J, Ericsson O, Burri C. Investigations of the metabolites of the trypanocidal drug melarsoprol. Clin Pharmacol Ther. 2000 May; 67(5):478-88. PMID: 10824626.
      View in: PubMed
    42. Burri C, Nkunku S, Merolle A, Smith T, Blum J, Brun R. Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial. Lancet. 2000 Apr 22; 355(9213):1419-25. PMID: 10791526.
      View in: PubMed
    43. Onyango JD, Burri C, Brun R. An automated biological assay to determine levels of the trypanocidal drug melarsoprol in biological fluids. Acta Trop. 2000 Jan 05; 74(1):95-100. PMID: 10643913.
      View in: PubMed
    44. Keiser J, Burri C. Physico-chemical properties of the trypanocidal drug melarsoprol. Acta Trop. 2000 Jan 05; 74(1):101-4. PMID: 10643914.
      View in: PubMed
    45. Nenortas E, Burri C, Shapiro TA. Antitrypanosomal activity of fluoroquinolones. Antimicrob Agents Chemother. 1999 Aug; 43(8):2066-8. PMID: 10428939.
      View in: PubMed
    46. Bronner U, Brun R, Doua F, Ericsson O, Burri C, Keiser J, Miézan TW, Boa YF, Rombo L, Gustafsson LL. Discrepancy in plasma melarsoprol concentrations between HPLC and bioassay methods in patients with T. gambiense sleeping sickness indicates that melarsoprol is metabolized. Trop Med Int Health. 1998 Nov; 3(11):913-7. PMID: 9855405.
      View in: PubMed
    47. Burri C, Bodley AL, Shapiro TA. Topoisomerases in kinetoplastids. Parasitol Today. 1996 Jun; 12(6):226-31. PMID: 15275202.
      View in: PubMed
    48. Burri C, Blum J, Brun R. Alternative application of melarsoprol for treatment of T. B. gambiense sleeping sickness. Preliminary results. Ann Soc Belg Med Trop. 1995 Mar; 75(1):65-71. PMID: 7794064.
      View in: PubMed
    49. Burri C, Onyango JD, Auma JE, Burudi EM, Brun R. Pharmacokinetics of melarsoprol in uninfected vervet monkeys. Acta Trop. 1994 Oct; 58(1):35-49. PMID: 7863853.
      View in: PubMed
    50. Lun ZR, Burri C, Menzinger M, Kaminsky R. Antiparasitic activity of diallyl trisulfide (Dasuansu) on human and animal pathogenic protozoa (Trypanosoma sp., Entamoeba histolytica and Giardia lamblia) in vitro. Ann Soc Belg Med Trop. 1994 Mar; 74(1):51-9. PMID: 8024350.
      View in: PubMed
    51. Burri C, Baltz T, Giroud C, Doua F, Welker HA, Brun R. Pharmacokinetic properties of the trypanocidal drug melarsoprol. Chemotherapy. 1993 Jul-Aug; 39(4):225-34. PMID: 8391966.
      View in: PubMed
    52. Burri C, Brun R. An in vitro bioassay for quantification of melarsoprol in serum and cerebrospinal fluid. Trop Med Parasitol. 1992 Dec; 43(4):223-5. PMID: 1293724.
      View in: PubMed
    Burri's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Physical Neighbors Expand Description
    _